SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-002851
Filing Date
2024-01-05
Accepted
2024-01-05 07:00:34
Documents
13
Period of Report
2024-01-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d657602d8k.htm   iXBRL 8-K 27146
2 EX-10.1 d657602dex101.htm EX-10.1 13403
  Complete submission text file 0001193125-24-002851.txt   166485

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20240103.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20240103_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20240103_pre.xml EX-101.PRE 11264
7 EXTRACTED XBRL INSTANCE DOCUMENT d657602d8k_htm.xml XML 3343
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 24514417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)